Lung Cancer Trial, Recruiting (NCT06451003)

Lung Cancer Trial, Recruiting NCT06451003 Sponsor: Medical University of South Carolina Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06451003 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are having surgery for cancer that involves removing part of the esophagus, stomach, pancreas, small intestine, colon, rectum, bladder, kidney, uterus, or ovaries
Your surgery is being performed at one of the three hospitals within the Medical University of South Carolina (MUSC) system

Who may not be able to join:

You have been taking strong blood-thinning medication (at treatment-level doses) in the 30 days before your surgery
You are started on strong blood-thinning medication (at treatment-level doses) after your surgery
You have moderate-to-severe kidney disease (confirm with trial site)
Your hospital stay after surgery lasts 30 days or longer
You do not respond to a survey that is part of the study (for the patient survey portion of the trial)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06451003

Sponsor: Medical University of South Carolina

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06451003

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are having surgery for cancer that involves removing part of the esophagus, stomach, pancreas, small intestine, colon, rectum, bladder, kidney, uterus, or ovaries
Your surgery is being performed at one of the three hospitals within the Medical University of South Carolina (MUSC) system

Who may not be able to join:

You have been taking strong blood-thinning medication (at treatment-level doses) in the 30 days before your surgery
You are started on strong blood-thinning medication (at treatment-level doses) after your surgery
You have moderate-to-severe kidney disease (confirm with trial site)
Your hospital stay after surgery lasts 30 days or longer
You do not respond to a survey that is part of the study (for the patient survey portion of the trial)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of South Carolina

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of eligible patients receiving venous thromboembolism (VTE) prophylaxis prescription; surgeon cluster level analysis; Proportion of patients adherent to pharmacologic extended venous thromboembolism prophylaxis (ePpx)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov